

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cholesterol esterification (GO:0010872) | 5.17285409 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 5.15386058 |
| 3 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.05665283 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.00091954 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.00091954 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.77934346 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.77934346 |
| 8 | amino sugar catabolic process (GO:0046348) | 4.70091879 |
| 9 | oligosaccharide catabolic process (GO:0009313) | 4.65960768 |
| 10 | glycolipid catabolic process (GO:0019377) | 4.64707466 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.58793527 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 4.46387650 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.35486183 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.35486183 |
| 15 | tryptophan catabolic process (GO:0006569) | 4.35486183 |
| 16 | ceramide catabolic process (GO:0046514) | 4.29091635 |
| 17 | low-density lipoprotein particle remodeling (GO:0034374) | 4.20371492 |
| 18 | tryptophan metabolic process (GO:0006568) | 4.18090980 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 4.15973904 |
| 20 | phospholipid efflux (GO:0033700) | 4.12234207 |
| 21 | reverse cholesterol transport (GO:0043691) | 4.04061004 |
| 22 | aldehyde catabolic process (GO:0046185) | 4.02817491 |
| 23 | sphingolipid catabolic process (GO:0030149) | 4.00804028 |
| 24 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.96737357 |
| 25 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.96737357 |
| 26 | folic acid transport (GO:0015884) | 3.90304243 |
| 27 | membrane lipid catabolic process (GO:0046466) | 3.89694821 |
| 28 | transferrin transport (GO:0033572) | 3.86021671 |
| 29 | phagosome maturation (GO:0090382) | 3.82901411 |
| 30 | bile acid biosynthetic process (GO:0006699) | 3.80407227 |
| 31 | metallo-sulfur cluster assembly (GO:0031163) | 3.79282546 |
| 32 | iron-sulfur cluster assembly (GO:0016226) | 3.79282546 |
| 33 | kynurenine metabolic process (GO:0070189) | 3.78733458 |
| 34 | cholesterol efflux (GO:0033344) | 3.72848571 |
| 35 | glyoxylate metabolic process (GO:0046487) | 3.63077758 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 3.61190239 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 3.61190239 |
| 38 | macromolecular complex remodeling (GO:0034367) | 3.61190239 |
| 39 | protein carboxylation (GO:0018214) | 3.59331164 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.59331164 |
| 41 | proteasome assembly (GO:0043248) | 3.58909213 |
| 42 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.56771650 |
| 43 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.56771650 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.56238263 |
| 45 | cofactor catabolic process (GO:0051187) | 3.47895500 |
| 46 | regulation of protein activation cascade (GO:2000257) | 3.47369604 |
| 47 | cellular biogenic amine catabolic process (GO:0042402) | 3.46858288 |
| 48 | amine catabolic process (GO:0009310) | 3.46858288 |
| 49 | protein insertion into membrane (GO:0051205) | 3.46046483 |
| 50 | trivalent inorganic cation transport (GO:0072512) | 3.41892947 |
| 51 | ferric iron transport (GO:0015682) | 3.41892947 |
| 52 | barbed-end actin filament capping (GO:0051016) | 3.39885790 |
| 53 | serine transport (GO:0032329) | 3.39391743 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 3.39257219 |
| 55 | sulfur amino acid catabolic process (GO:0000098) | 3.38213982 |
| 56 | amino acid salvage (GO:0043102) | 3.37880541 |
| 57 | L-methionine salvage (GO:0071267) | 3.37880541 |
| 58 | L-methionine biosynthetic process (GO:0071265) | 3.37880541 |
| 59 | phospholipid homeostasis (GO:0055091) | 3.35048195 |
| 60 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.34245541 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 3.34046649 |
| 62 | pentose metabolic process (GO:0019321) | 3.33120615 |
| 63 | negative regulation of mitochondrion organization (GO:0010823) | 3.33109446 |
| 64 | response to acidic pH (GO:0010447) | 3.29573035 |
| 65 | regulation of complement activation (GO:0030449) | 3.29114031 |
| 66 | regulation of cholesterol storage (GO:0010885) | 3.28408524 |
| 67 | urea metabolic process (GO:0019627) | 3.27237541 |
| 68 | urea cycle (GO:0000050) | 3.27237541 |
| 69 | NAD biosynthetic process (GO:0009435) | 3.24727145 |
| 70 | neutrophil activation involved in immune response (GO:0002283) | 3.21708994 |
| 71 | negative regulation of mast cell activation (GO:0033004) | 3.21605599 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 3.20123238 |
| 73 | alpha-linolenic acid metabolic process (GO:0036109) | 3.18917067 |
| 74 | negative regulation of fibrinolysis (GO:0051918) | 3.18573251 |
| 75 | lytic vacuole organization (GO:0080171) | 3.13345924 |
| 76 | lysosome organization (GO:0007040) | 3.13345924 |
| 77 | positive regulation of mitochondrial fission (GO:0090141) | 3.11710198 |
| 78 | bile acid metabolic process (GO:0008206) | 3.09679144 |
| 79 | positive regulation of interferon-alpha production (GO:0032727) | 3.08798462 |
| 80 | protein localization to endosome (GO:0036010) | 3.08748742 |
| 81 | protein maturation by protein folding (GO:0022417) | 3.05152297 |
| 82 | base-excision repair, AP site formation (GO:0006285) | 3.05099863 |
| 83 | ganglioside metabolic process (GO:0001573) | 3.05072925 |
| 84 | adhesion of symbiont to host cell (GO:0044650) | 3.00299776 |
| 85 | virion attachment to host cell (GO:0019062) | 3.00299776 |
| 86 | adhesion of symbiont to host (GO:0044406) | 2.99150851 |
| 87 | GDP-mannose metabolic process (GO:0019673) | 2.98458767 |
| 88 | L-ascorbic acid metabolic process (GO:0019852) | 2.98409181 |
| 89 | complement activation, classical pathway (GO:0006958) | 2.97676960 |
| 90 | amyloid precursor protein catabolic process (GO:0042987) | 2.95217729 |
| 91 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.95191348 |
| 92 | * basic amino acid transport (GO:0015802) | 2.94950730 |
| 93 | regulation of interferon-alpha production (GO:0032647) | 2.94673013 |
| 94 | Golgi transport vesicle coating (GO:0048200) | 2.93607566 |
| 95 | COPI coating of Golgi vesicle (GO:0048205) | 2.93607566 |
| 96 | urate metabolic process (GO:0046415) | 2.93540144 |
| 97 | cellular response to arsenic-containing substance (GO:0071243) | 2.92470349 |
| 98 | indolalkylamine metabolic process (GO:0006586) | 2.92334092 |
| 99 | plasma lipoprotein particle assembly (GO:0034377) | 2.89572254 |
| 100 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88120052 |
| 101 | complement activation, alternative pathway (GO:0006957) | 2.87320328 |
| 102 | cellular iron ion homeostasis (GO:0006879) | 2.86789817 |
| 103 | positive regulation of coagulation (GO:0050820) | 2.85870839 |
| 104 | glucose 6-phosphate metabolic process (GO:0051156) | 2.85795827 |
| 105 | serine family amino acid catabolic process (GO:0009071) | 2.85706706 |
| 106 | regulation of cholesterol metabolic process (GO:0090181) | 2.85003892 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 2.84097423 |
| 108 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.84011211 |
| 109 | protein retention in ER lumen (GO:0006621) | 2.83970245 |
| 110 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.82933512 |
| 111 | response to peptidoglycan (GO:0032494) | 2.82762717 |
| 112 | complement activation (GO:0006956) | 2.82492820 |
| 113 | positive regulation of blood coagulation (GO:0030194) | 2.82462723 |
| 114 | positive regulation of hemostasis (GO:1900048) | 2.82462723 |
| 115 | regulation of fibrinolysis (GO:0051917) | 2.81406304 |
| 116 | NIK/NF-kappaB signaling (GO:0038061) | 2.81140684 |
| 117 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.80969366 |
| 118 | N-acetylneuraminate metabolic process (GO:0006054) | 2.80926051 |
| 119 | sulfur amino acid biosynthetic process (GO:0000097) | 2.79830804 |
| 120 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79528931 |
| 121 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.78436212 |
| 122 | glycine metabolic process (GO:0006544) | 2.77602021 |
| 123 | low-density lipoprotein particle clearance (GO:0034383) | 2.76834994 |
| 124 | mannose metabolic process (GO:0006013) | 2.76305317 |
| 125 | glycosphingolipid metabolic process (GO:0006687) | 2.75910986 |
| 126 | nucleotide salvage (GO:0043173) | 2.74935594 |
| 127 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.74773088 |
| 128 | cysteine metabolic process (GO:0006534) | 2.74673235 |
| 129 | tyrosine metabolic process (GO:0006570) | 2.74560179 |
| 130 | arginine metabolic process (GO:0006525) | 2.73698420 |
| 131 | iron ion transport (GO:0006826) | 2.73550165 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.73520714 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.73520714 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 2.73520714 |
| 135 | positive regulation by symbiont of host defense response (GO:0052509) | 2.73520714 |
| 136 | modulation by symbiont of host defense response (GO:0052031) | 2.73520714 |
| 137 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.73520714 |
| 138 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.72902598 |
| 139 | pH reduction (GO:0045851) | 2.72320082 |
| 140 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.72034507 |
| 141 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.72034507 |
| 142 | lipoprotein metabolic process (GO:0042157) | 2.71249126 |
| 143 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.71221424 |
| 144 | serine family amino acid biosynthetic process (GO:0009070) | 2.70985125 |
| 145 | protein-lipid complex subunit organization (GO:0071825) | 2.70331767 |
| 146 | alpha-amino acid catabolic process (GO:1901606) | 2.70167041 |
| 147 | acylglycerol homeostasis (GO:0055090) | 2.69378486 |
| 148 | triglyceride homeostasis (GO:0070328) | 2.69378486 |
| 149 | polyamine biosynthetic process (GO:0006596) | 2.67009542 |
| 150 | negative regulation of interleukin-12 production (GO:0032695) | 2.66994632 |
| 151 | L-serine transport (GO:0015825) | 2.65495362 |
| 152 | protein-lipid complex assembly (GO:0065005) | 2.65256421 |
| 153 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.65156503 |
| 154 | negative regulation of cholesterol transport (GO:0032375) | 2.65148782 |
| 155 | negative regulation of sterol transport (GO:0032372) | 2.65148782 |
| 156 | amino-acid betaine metabolic process (GO:0006577) | 2.64665519 |
| 157 | homocysteine metabolic process (GO:0050667) | 2.64569689 |
| 158 | glycoside metabolic process (GO:0016137) | 2.64182197 |
| 159 | glycerophospholipid catabolic process (GO:0046475) | 2.64127474 |
| 160 | pyrimidine-containing compound salvage (GO:0008655) | 2.63752525 |
| 161 | pyrimidine nucleoside salvage (GO:0043097) | 2.63752525 |
| 162 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.63716336 |
| 163 | regulation of mononuclear cell migration (GO:0071675) | 2.63309250 |
| 164 | protein activation cascade (GO:0072376) | 2.62458153 |
| 165 | viral protein processing (GO:0019082) | 2.62392813 |
| 166 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.60061266 |
| 167 | positive regulation of protein homooligomerization (GO:0032464) | 2.59936173 |
| 168 | decidualization (GO:0046697) | 2.59558889 |
| 169 | hyaluronan catabolic process (GO:0030214) | 2.58403786 |
| 170 | glycosylceramide metabolic process (GO:0006677) | 2.57952764 |
| 171 | response to pH (GO:0009268) | 2.56361909 |
| 172 | glial cell migration (GO:0008347) | 2.55387188 |
| 173 | regulation of superoxide anion generation (GO:0032928) | 2.55155236 |
| 174 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.54632900 |
| 175 | intracellular pH reduction (GO:0051452) | 2.51595709 |
| 176 | oligosaccharide metabolic process (GO:0009311) | 2.51118741 |
| 177 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.50322592 |
| 178 | carbohydrate phosphorylation (GO:0046835) | 2.48544382 |
| 179 | virion assembly (GO:0019068) | 2.47833032 |
| 180 | response to xenobiotic stimulus (GO:0009410) | 2.47177076 |
| 181 | cellular transition metal ion homeostasis (GO:0046916) | 2.46657850 |
| 182 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.46197066 |
| 183 | response to thyroid hormone (GO:0097066) | 2.44318302 |
| 184 | glucose catabolic process (GO:0006007) | 2.43129877 |
| 185 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.43009970 |
| 186 | sphingosine metabolic process (GO:0006670) | 2.42701791 |
| 187 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.42404266 |
| 188 | regulation of mitochondrial fission (GO:0090140) | 2.41661227 |
| 189 | proline biosynthetic process (GO:0006561) | 2.40781565 |
| 190 | positive regulation of TOR signaling (GO:0032008) | 2.40460955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.16381609 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.47055615 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.05302331 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.94676131 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.78631027 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.75517282 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.46968157 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.42461093 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.30381765 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.29868506 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.95117530 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.84569018 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.51843810 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.46156255 |
| 15 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.40462032 |
| 16 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.23311014 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.18020249 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.12308884 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.12093841 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.10849450 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09633665 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.07568666 |
| 23 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.06882869 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.06449781 |
| 25 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00278567 |
| 26 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.96806585 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.96668852 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92312018 |
| 29 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.85326106 |
| 30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.84790141 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82790501 |
| 32 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.78355222 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77687222 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74623580 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72365986 |
| 36 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.72272280 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.71936049 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71634838 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69952182 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66894296 |
| 41 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.62318593 |
| 42 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58820406 |
| 43 | P68_20966046_ChIP-Seq_HELA_Human | 1.57678512 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56091710 |
| 45 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.56037938 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52673350 |
| 47 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.52577344 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51451081 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51203979 |
| 50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47447314 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.47392808 |
| 52 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43956442 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40632282 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40610336 |
| 55 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38665306 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37978026 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36317581 |
| 58 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36288125 |
| 59 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.34480037 |
| 60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.32413776 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30036891 |
| 62 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29524842 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29131117 |
| 64 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26917179 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26793675 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26645129 |
| 67 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.25854233 |
| 68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25782982 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25265405 |
| 70 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23636558 |
| 71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23568056 |
| 72 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21564236 |
| 73 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20888215 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19697600 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18444905 |
| 76 | SA1_27219007_Chip-Seq_Bcells_Human | 1.18420545 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18186362 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18114609 |
| 79 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.17999634 |
| 80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17579303 |
| 81 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16593131 |
| 82 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16234219 |
| 83 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16118311 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15305083 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15252125 |
| 86 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.15184368 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13863099 |
| 88 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.13378193 |
| 89 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.13318489 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12842918 |
| 91 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12734603 |
| 92 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.12534712 |
| 93 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.11336255 |
| 94 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.11293144 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11159682 |
| 96 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.10596452 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09849701 |
| 98 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.09283637 |
| 99 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09197342 |
| 100 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08066227 |
| 101 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07376551 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06826582 |
| 103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06108385 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05319231 |
| 105 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03276786 |
| 106 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02947864 |
| 107 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.02794645 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02584599 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02541741 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01998119 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01530829 |
| 112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01189416 |
| 113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01047590 |
| 114 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.99346136 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98403348 |
| 116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98324436 |
| 117 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.96253800 |
| 118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94780246 |
| 119 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93011071 |
| 120 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91982393 |
| 121 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91569716 |
| 122 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.91467783 |
| 123 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91032913 |
| 124 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90902334 |
| 125 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89729559 |
| 126 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89642143 |
| 127 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89285013 |
| 128 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88054457 |
| 129 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.87643812 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86442502 |
| 131 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.84887564 |
| 132 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84298411 |
| 133 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84148868 |
| 134 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.83528846 |
| 135 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.82913636 |
| 136 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82464418 |
| 137 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.82430232 |
| 138 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82254657 |
| 139 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80773888 |
| 140 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80596383 |
| 141 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80259333 |
| 142 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79751614 |
| 143 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.79627281 |
| 144 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79393733 |
| 145 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.78753566 |
| 146 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.77575828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 6.01033352 |
| 2 | MP0005360_urolithiasis | 4.64874242 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.60594451 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.54376124 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.24567974 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 3.11227412 |
| 7 | MP0005365_abnormal_bile_salt | 3.05670081 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.02227504 |
| 9 | MP0005332_abnormal_amino_acid | 2.67524567 |
| 10 | MP0009278_abnormal_bone_marrow | 2.37208789 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.34416433 |
| 12 | MP0006054_spinal_hemorrhage | 2.30658074 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.28748575 |
| 14 | MP0005451_abnormal_body_composition | 2.14189713 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.11553447 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.09815914 |
| 17 | MP0005083_abnormal_biliary_tract | 2.02363653 |
| 18 | MP0003303_peritoneal_inflammation | 2.01834419 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 1.95822814 |
| 20 | MP0003195_calcinosis | 1.95729967 |
| 21 | MP0001542_abnormal_bone_strength | 1.95535908 |
| 22 | MP0006082_CNS_inflammation | 1.93308962 |
| 23 | MP0003186_abnormal_redox_activity | 1.91960987 |
| 24 | MP0000604_amyloidosis | 1.91173061 |
| 25 | MP0001790_abnormal_immune_system | 1.90376175 |
| 26 | MP0005387_immune_system_phenotype | 1.90376175 |
| 27 | MP0003252_abnormal_bile_duct | 1.85432426 |
| 28 | MP0001545_abnormal_hematopoietic_system | 1.80083310 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.80083310 |
| 30 | MP0008260_abnormal_autophagy | 1.79481065 |
| 31 | MP0002419_abnormal_innate_immunity | 1.79173864 |
| 32 | MP0003436_decreased_susceptibility_to | 1.78580201 |
| 33 | MP0003075_altered_response_to | 1.76925265 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.75868048 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.68006379 |
| 36 | MP0004883_abnormal_blood_vessel | 1.64367324 |
| 37 | MP0002254_reproductive_system_inflammat | 1.64263668 |
| 38 | MP0000609_abnormal_liver_physiology | 1.61735404 |
| 39 | MP0001853_heart_inflammation | 1.57705108 |
| 40 | MP0009697_abnormal_copulation | 1.55602938 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.53602190 |
| 42 | MP0009764_decreased_sensitivity_to | 1.51021659 |
| 43 | MP0001764_abnormal_homeostasis | 1.50635960 |
| 44 | MP0004510_myositis | 1.47960802 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.45984862 |
| 46 | MP0008469_abnormal_protein_level | 1.42223260 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.40491390 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.40394220 |
| 49 | MP0004858_abnormal_nervous_system | 1.40245030 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.39502318 |
| 51 | MP0002653_abnormal_ependyma_morphology | 1.37892493 |
| 52 | MP0001800_abnormal_humoral_immune | 1.34910197 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.33710491 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.33605704 |
| 55 | MP0001727_abnormal_embryo_implantation | 1.32785630 |
| 56 | MP0000358_abnormal_cell_content/ | 1.31737935 |
| 57 | MP0005671_abnormal_response_to | 1.30887629 |
| 58 | MP0004782_abnormal_surfactant_physiolog | 1.30854207 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 1.29012325 |
| 60 | MP0002723_abnormal_immune_serum | 1.26264647 |
| 61 | MP0001958_emphysema | 1.22460711 |
| 62 | MP0000858_altered_metastatic_potential | 1.21092974 |
| 63 | MP0002090_abnormal_vision | 1.20123818 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.18380252 |
| 65 | MP0009785_altered_susceptibility_to | 1.18172793 |
| 66 | MP0000685_abnormal_immune_system | 1.15804053 |
| 67 | MP0002405_respiratory_system_inflammati | 1.14967955 |
| 68 | MP0005025_abnormal_response_to | 1.14389091 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.14200693 |
| 70 | MP0005164_abnormal_response_to | 1.13169734 |
| 71 | MP0002136_abnormal_kidney_physiology | 1.11716682 |
| 72 | MP0005408_hypopigmentation | 1.11712632 |
| 73 | MP0001756_abnormal_urination | 1.09954714 |
| 74 | MP0004947_skin_inflammation | 1.09850335 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.09266925 |
| 76 | MP0005310_abnormal_salivary_gland | 1.09174584 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.09165823 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 1.08617499 |
| 79 | MP0003011_delayed_dark_adaptation | 1.08001278 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07138509 |
| 81 | MP0003279_aneurysm | 1.06634980 |
| 82 | MP0003329_amyloid_beta_deposits | 1.06360741 |
| 83 | MP0001533_abnormal_skeleton_physiology | 1.04893013 |
| 84 | MP0010386_abnormal_urinary_bladder | 1.04496501 |
| 85 | MP0001819_abnormal_immune_cell | 1.03622445 |
| 86 | MP0003718_maternal_effect | 1.03413570 |
| 87 | MP0002420_abnormal_adaptive_immunity | 1.02231973 |
| 88 | MP0000681_abnormal_thyroid_gland | 1.01630524 |
| 89 | MP0003172_abnormal_lysosome_physiology | 1.01393744 |
| 90 | MP0004233_abnormal_muscle_weight | 1.01349462 |
| 91 | MP0000598_abnormal_liver_morphology | 1.01214915 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.99901166 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.99685575 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.95806190 |
| 95 | MP0003724_increased_susceptibility_to | 0.93377813 |
| 96 | MP0000371_diluted_coat_color | 0.92179177 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.91430857 |
| 98 | MP0003634_abnormal_glial_cell | 0.91144976 |
| 99 | MP0002736_abnormal_nociception_after | 0.90518742 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.90106205 |
| 101 | MP0000538_abnormal_urinary_bladder | 0.89968320 |
| 102 | MP0009763_increased_sensitivity_to | 0.88062964 |
| 103 | MP0003690_abnormal_glial_cell | 0.87679831 |
| 104 | MP0003123_paternal_imprinting | 0.86559832 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.86302455 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.85979314 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.84350063 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.84245362 |
| 109 | MP0005647_abnormal_sex_gland | 0.81034703 |
| 110 | MP0000678_abnormal_parathyroid_gland | 0.80820232 |
| 111 | MP0008007_abnormal_cellular_replicative | 0.79490687 |
| 112 | MP0000716_abnormal_immune_system | 0.77996054 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.76932456 |
| 114 | MP0010030_abnormal_orbit_morphology | 0.75735000 |
| 115 | MP0000249_abnormal_blood_vessel | 0.75471725 |
| 116 | MP0005166_decreased_susceptibility_to | 0.75392375 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.73723439 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.72986451 |
| 119 | MP0003879_abnormal_hair_cell | 0.72097440 |
| 120 | MP0000750_abnormal_muscle_regeneration | 0.71487640 |
| 121 | MP0002132_abnormal_respiratory_system | 0.67197214 |
| 122 | MP0001849_ear_inflammation | 0.67064824 |
| 123 | MP0002429_abnormal_blood_cell | 0.65650707 |
| 124 | MP0002722_abnormal_immune_system | 0.65633495 |
| 125 | MP0000920_abnormal_myelination | 0.65074630 |
| 126 | MP0005636_abnormal_mineral_homeostasis | 0.64860236 |
| 127 | MP0005248_abnormal_Harderian_gland | 0.64457868 |
| 128 | MP0000343_altered_response_to | 0.63410567 |
| 129 | MP0006036_abnormal_mitochondrial_physio | 0.60689486 |
| 130 | MP0003786_premature_aging | 0.60380639 |
| 131 | MP0001243_abnormal_dermal_layer | 0.60027952 |
| 132 | MP0001915_intracranial_hemorrhage | 0.59692157 |
| 133 | MP0005023_abnormal_wound_healing | 0.59634326 |
| 134 | MP0002229_neurodegeneration | 0.57402249 |
| 135 | MP0001529_abnormal_vocalization | 0.56439985 |
| 136 | MP0005084_abnormal_gallbladder_morpholo | 0.56367803 |
| 137 | MP0002837_dystrophic_cardiac_calcinosis | 0.56203661 |
| 138 | MP0003795_abnormal_bone_structure | 0.55418521 |
| 139 | MP0002135_abnormal_kidney_morphology | 0.55240720 |
| 140 | MP0005075_abnormal_melanosome_morpholog | 0.55005237 |
| 141 | MP0005390_skeleton_phenotype | 0.51582753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.51933095 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 4.32338621 |
| 3 | Loss of speech (HP:0002371) | 4.30074909 |
| 4 | Xanthomatosis (HP:0000991) | 4.15914187 |
| 5 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.93853886 |
| 6 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.93853886 |
| 7 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.93853886 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 3.90417401 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.71947424 |
| 10 | Joint hemorrhage (HP:0005261) | 3.69374376 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.59789524 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.57285864 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.45048128 |
| 14 | Axonal loss (HP:0003447) | 3.42439320 |
| 15 | Complement deficiency (HP:0004431) | 3.39280998 |
| 16 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.38720483 |
| 17 | Mucopolysacchariduria (HP:0008155) | 3.38720483 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.34841234 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.29828764 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28157554 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.23836837 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 3.16487970 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.16487970 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.16487970 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.06172076 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.03345264 |
| 27 | Nuclear cataract (HP:0100018) | 3.00395199 |
| 28 | Glomerulonephritis (HP:0000099) | 2.95788773 |
| 29 | Hyperlipoproteinemia (HP:0010980) | 2.95749848 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.93201562 |
| 31 | Mitral stenosis (HP:0001718) | 2.90141939 |
| 32 | J-shaped sella turcica (HP:0002680) | 2.81551126 |
| 33 | Abnormality of complement system (HP:0005339) | 2.80783184 |
| 34 | Prolonged neonatal jaundice (HP:0006579) | 2.78582399 |
| 35 | Diminished motivation (HP:0000745) | 2.78371423 |
| 36 | Mutism (HP:0002300) | 2.77833791 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 2.77803567 |
| 38 | Myocardial infarction (HP:0001658) | 2.74461510 |
| 39 | Petechiae (HP:0000967) | 2.73380944 |
| 40 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.73134634 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.70083339 |
| 42 | Disinhibition (HP:0000734) | 2.68828842 |
| 43 | Generalized aminoaciduria (HP:0002909) | 2.67641536 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.67057292 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.64348665 |
| 46 | Hyperglycinuria (HP:0003108) | 2.63482833 |
| 47 | Apathy (HP:0000741) | 2.62942955 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.62377123 |
| 49 | Upper motor neuron abnormality (HP:0002127) | 2.60296840 |
| 50 | Cardiomegaly (HP:0001640) | 2.57817626 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55016261 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 2.51221320 |
| 53 | Cholecystitis (HP:0001082) | 2.51221320 |
| 54 | Hand muscle atrophy (HP:0009130) | 2.49725934 |
| 55 | Hypolipoproteinemia (HP:0010981) | 2.49308903 |
| 56 | Fat malabsorption (HP:0002630) | 2.48794829 |
| 57 | Personality changes (HP:0000751) | 2.48727149 |
| 58 | Upper limb amyotrophy (HP:0009129) | 2.48165969 |
| 59 | Distal upper limb amyotrophy (HP:0007149) | 2.48165969 |
| 60 | Achilles tendon contracture (HP:0001771) | 2.45043468 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.44914872 |
| 62 | Retinal atrophy (HP:0001105) | 2.43764134 |
| 63 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43436003 |
| 64 | Eczematoid dermatitis (HP:0000976) | 2.41549723 |
| 65 | Increased serum ferritin (HP:0003281) | 2.41085973 |
| 66 | Neuronal loss in central nervous system (HP:0002529) | 2.39472840 |
| 67 | Hypoglycemic coma (HP:0001325) | 2.38635826 |
| 68 | Hepatosplenomegaly (HP:0001433) | 2.37954563 |
| 69 | Nausea (HP:0002018) | 2.37562699 |
| 70 | Hyperglycinemia (HP:0002154) | 2.37083838 |
| 71 | Renal cortical cysts (HP:0000803) | 2.36596608 |
| 72 | Hyperammonemia (HP:0001987) | 2.35733038 |
| 73 | Opisthotonus (HP:0002179) | 2.31926424 |
| 74 | Abnormality of nucleobase metabolism (HP:0010932) | 2.31411820 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31169159 |
| 76 | Gingival bleeding (HP:0000225) | 2.28674838 |
| 77 | Proximal tubulopathy (HP:0000114) | 2.27426775 |
| 78 | Cerebral hypomyelination (HP:0006808) | 2.26453502 |
| 79 | Spastic paraparesis (HP:0002313) | 2.25665256 |
| 80 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.25624754 |
| 81 | Steatorrhea (HP:0002570) | 2.22086524 |
| 82 | Abnormality of the Achilles tendon (HP:0005109) | 2.21337141 |
| 83 | Recurrent skin infections (HP:0001581) | 2.21260986 |
| 84 | Poor head control (HP:0002421) | 2.18742760 |
| 85 | Paraparesis (HP:0002385) | 2.16573264 |
| 86 | Abnormality of glycine metabolism (HP:0010895) | 2.14692325 |
| 87 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14692325 |
| 88 | Glycosuria (HP:0003076) | 2.13816754 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.13816754 |
| 90 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13147004 |
| 91 | Lethargy (HP:0001254) | 2.13144620 |
| 92 | Stridor (HP:0010307) | 2.11054907 |
| 93 | Abnormality of macrophages (HP:0004311) | 2.10727789 |
| 94 | Abnormality of purine metabolism (HP:0004352) | 2.10550413 |
| 95 | Pathologic fracture (HP:0002756) | 2.08758840 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08507954 |
| 97 | Polyphagia (HP:0002591) | 2.07995997 |
| 98 | Vertebral compression fractures (HP:0002953) | 2.07536066 |
| 99 | Abnormality of serum amino acid levels (HP:0003112) | 2.05798535 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 2.04775230 |
| 101 | Hyperbilirubinemia (HP:0002904) | 2.03049299 |
| 102 | Reticulocytosis (HP:0001923) | 2.02971274 |
| 103 | Thoracic kyphosis (HP:0002942) | 2.02135857 |
| 104 | Vascular calcification (HP:0004934) | 2.01995490 |
| 105 | Hypercholesterolemia (HP:0003124) | 2.01828881 |
| 106 | Microretrognathia (HP:0000308) | 2.00419991 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00335114 |
| 108 | Sensorimotor neuropathy (HP:0007141) | 1.98952914 |
| 109 | Neurofibrillary tangles (HP:0002185) | 1.98074759 |
| 110 | Hyperthyroidism (HP:0000836) | 1.97778129 |
| 111 | Elevated alkaline phosphatase (HP:0003155) | 1.97451698 |
| 112 | Pustule (HP:0200039) | 1.96977217 |
| 113 | Cheilitis (HP:0100825) | 1.95707454 |
| 114 | Agitation (HP:0000713) | 1.95610760 |
| 115 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.95252449 |
| 116 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.95215829 |
| 117 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.95215829 |
| 118 | Adrenal hypoplasia (HP:0000835) | 1.93083408 |
| 119 | Irritability (HP:0000737) | 1.92845048 |
| 120 | Purpura (HP:0000979) | 1.91082565 |
| 121 | Abnormality of proline metabolism (HP:0010907) | 1.90915155 |
| 122 | Hydroxyprolinuria (HP:0003080) | 1.90915155 |
| 123 | Basal ganglia calcification (HP:0002135) | 1.90896725 |
| 124 | Agnosia (HP:0010524) | 1.90605692 |
| 125 | Dementia (HP:0000726) | 1.90373946 |
| 126 | Metaphyseal irregularity (HP:0003025) | 1.89587050 |
| 127 | Epiphyseal stippling (HP:0010655) | 1.89077849 |
| 128 | Dysostosis multiplex (HP:0000943) | 1.88636841 |
| 129 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.88586766 |
| 130 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88487679 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.88444246 |
| 132 | Hypokinesia (HP:0002375) | 1.88335874 |
| 133 | Cerebral edema (HP:0002181) | 1.87943388 |
| 134 | Supranuclear gaze palsy (HP:0000605) | 1.83950646 |
| 135 | Ragged-red muscle fibers (HP:0003200) | 1.83208247 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82394538 |
| 137 | Anorexia (HP:0002039) | 1.81912905 |
| 138 | Progressive neurologic deterioration (HP:0002344) | 1.79002660 |
| 139 | Tetraparesis (HP:0002273) | 1.78922701 |
| 140 | Rough bone trabeculation (HP:0100670) | 1.78176872 |
| 141 | Dicarboxylic aciduria (HP:0003215) | 1.77856126 |
| 142 | Cortical visual impairment (HP:0100704) | 1.75803336 |
| 143 | Abnormality of the gallbladder (HP:0005264) | 1.74189932 |
| 144 | Joint stiffness (HP:0001387) | 1.71395594 |
| 145 | Mesangial abnormality (HP:0001966) | 1.71001512 |
| 146 | Amyloidosis (HP:0011034) | 1.70084009 |
| 147 | Myoclonus (HP:0001336) | 1.65619761 |
| 148 | Parakeratosis (HP:0001036) | 1.63428660 |
| 149 | Abnormal protein glycosylation (HP:0012346) | 1.62095957 |
| 150 | Abnormal glycosylation (HP:0012345) | 1.62095957 |
| 151 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.62095957 |
| 152 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.62095957 |
| 153 | Abnormal trabecular bone morphology (HP:0100671) | 1.61890905 |
| 154 | Acute necrotizing encephalopathy (HP:0006965) | 1.61750168 |
| 155 | Protuberant abdomen (HP:0001538) | 1.61297267 |
| 156 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.61165189 |
| 157 | Acute encephalopathy (HP:0006846) | 1.60923356 |
| 158 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.60131044 |
| 159 | Type I transferrin isoform profile (HP:0003642) | 1.58877015 |
| 160 | Increased muscle lipid content (HP:0009058) | 1.58368877 |
| 161 | Natal tooth (HP:0000695) | 1.57431853 |
| 162 | Broad distal phalanx of finger (HP:0009836) | 1.57234166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.02156082 |
| 2 | MAP3K14 | 3.12008907 |
| 3 | PRPF4B | 2.77557453 |
| 4 | AKT3 | 2.63025291 |
| 5 | BUB1 | 2.49221230 |
| 6 | EPHA2 | 2.41065601 |
| 7 | SIK3 | 2.34596648 |
| 8 | IRAK4 | 2.34475636 |
| 9 | ERN1 | 2.32076935 |
| 10 | BLK | 2.22287631 |
| 11 | BCKDK | 2.20869325 |
| 12 | MAP2K3 | 2.18265062 |
| 13 | CSNK1G3 | 2.03504518 |
| 14 | TYK2 | 2.01524568 |
| 15 | TGFBR2 | 2.00253985 |
| 16 | TBK1 | 1.98814894 |
| 17 | MAP4K1 | 1.88092220 |
| 18 | GRK7 | 1.87579611 |
| 19 | FGFR4 | 1.84834902 |
| 20 | TAOK1 | 1.83834415 |
| 21 | ICK | 1.81031267 |
| 22 | KIT | 1.75953067 |
| 23 | EIF2AK1 | 1.69840030 |
| 24 | SMG1 | 1.67821960 |
| 25 | CSNK1G2 | 1.65906576 |
| 26 | CLK1 | 1.64524220 |
| 27 | PRKD2 | 1.63889698 |
| 28 | MAP3K3 | 1.57191076 |
| 29 | SGK2 | 1.53795057 |
| 30 | IKBKE | 1.53730588 |
| 31 | CSNK1A1L | 1.51339602 |
| 32 | TIE1 | 1.49610335 |
| 33 | CASK | 1.49113835 |
| 34 | PRKD3 | 1.45588050 |
| 35 | EIF2AK2 | 1.44967988 |
| 36 | YES1 | 1.41637115 |
| 37 | IKBKB | 1.31900675 |
| 38 | CSNK1G1 | 1.30775017 |
| 39 | PBK | 1.30539348 |
| 40 | PINK1 | 1.28831896 |
| 41 | CAMK1D | 1.28246669 |
| 42 | STK38L | 1.28160696 |
| 43 | STK16 | 1.22907653 |
| 44 | DDR2 | 1.22444896 |
| 45 | ADRBK2 | 1.19390969 |
| 46 | SGK223 | 1.18709024 |
| 47 | SGK494 | 1.18709024 |
| 48 | ZAK | 1.17569050 |
| 49 | KDR | 1.17514798 |
| 50 | STK10 | 1.17068107 |
| 51 | CAMKK2 | 1.16977364 |
| 52 | SGK3 | 1.12098547 |
| 53 | DAPK3 | 1.11475247 |
| 54 | EPHB1 | 1.11053465 |
| 55 | TRIB3 | 1.11021806 |
| 56 | NEK9 | 1.10047566 |
| 57 | NME2 | 1.08292221 |
| 58 | ABL2 | 1.06321441 |
| 59 | GRK1 | 1.03858952 |
| 60 | MAP3K11 | 1.03642756 |
| 61 | DYRK3 | 1.03426812 |
| 62 | PIM1 | 1.03128665 |
| 63 | ZAP70 | 0.99172383 |
| 64 | TSSK6 | 0.99069671 |
| 65 | MAP2K7 | 0.98343980 |
| 66 | PLK4 | 0.96189647 |
| 67 | SIK1 | 0.95829005 |
| 68 | IRAK2 | 0.95670636 |
| 69 | MARK3 | 0.95242646 |
| 70 | TESK2 | 0.95203281 |
| 71 | BCR | 0.95132195 |
| 72 | EPHB2 | 0.95112201 |
| 73 | TRPM7 | 0.94743930 |
| 74 | EIF2AK3 | 0.91873226 |
| 75 | LIMK1 | 0.91573269 |
| 76 | BMPR2 | 0.91432325 |
| 77 | PIM2 | 0.88182101 |
| 78 | SYK | 0.86755013 |
| 79 | DAPK1 | 0.85940434 |
| 80 | PIK3CG | 0.85741700 |
| 81 | LYN | 0.85667530 |
| 82 | BRAF | 0.85199543 |
| 83 | CSK | 0.84409495 |
| 84 | JAK1 | 0.80858993 |
| 85 | DYRK1B | 0.78180605 |
| 86 | MATK | 0.76964334 |
| 87 | CHUK | 0.76191754 |
| 88 | SCYL2 | 0.75605214 |
| 89 | PRKCI | 0.73183424 |
| 90 | IRAK1 | 0.68232774 |
| 91 | RPS6KA2 | 0.67388557 |
| 92 | MAP4K2 | 0.66897674 |
| 93 | MAP3K8 | 0.65762969 |
| 94 | PDK2 | 0.65216622 |
| 95 | MAP3K6 | 0.65163695 |
| 96 | VRK2 | 0.64582859 |
| 97 | TAOK2 | 0.64532139 |
| 98 | TESK1 | 0.64335952 |
| 99 | ITK | 0.64032483 |
| 100 | PAK4 | 0.60268528 |
| 101 | JAK3 | 0.59371862 |
| 102 | CSF1R | 0.58740214 |
| 103 | AURKA | 0.58730816 |
| 104 | MARK2 | 0.57577303 |
| 105 | PLK2 | 0.56343192 |
| 106 | BTK | 0.55881006 |
| 107 | EPHA3 | 0.54798591 |
| 108 | DYRK2 | 0.54477897 |
| 109 | MAP2K2 | 0.54095589 |
| 110 | TNK2 | 0.54087020 |
| 111 | MAP3K1 | 0.52619086 |
| 112 | CDC42BPA | 0.51628966 |
| 113 | PRKCD | 0.51577897 |
| 114 | STK4 | 0.50841374 |
| 115 | TLK1 | 0.50190055 |
| 116 | SRPK1 | 0.50132389 |
| 117 | MAP3K5 | 0.49807576 |
| 118 | PTK2 | 0.49768199 |
| 119 | LMTK2 | 0.49303588 |
| 120 | PAK1 | 0.48975318 |
| 121 | GSK3A | 0.48847930 |
| 122 | RPS6KL1 | 0.48472565 |
| 123 | RPS6KC1 | 0.48472565 |
| 124 | MAP2K6 | 0.47390852 |
| 125 | CAMK2G | 0.47038184 |
| 126 | RPS6KA4 | 0.46929146 |
| 127 | HCK | 0.45879232 |
| 128 | PAK6 | 0.44242821 |
| 129 | MAPKAPK3 | 0.43902419 |
| 130 | MAPK7 | 0.43451232 |
| 131 | GRK6 | 0.43176437 |
| 132 | DAPK2 | 0.41591161 |
| 133 | LCK | 0.40713525 |
| 134 | MST1R | 0.40390387 |
| 135 | AKT2 | 0.39390311 |
| 136 | CDK14 | 0.39151453 |
| 137 | ERBB4 | 0.39000079 |
| 138 | PRKG2 | 0.38878080 |
| 139 | FER | 0.38628325 |
| 140 | RPS6KA5 | 0.38484038 |
| 141 | RPS6KA6 | 0.38354424 |
| 142 | MAPK11 | 0.38139124 |
| 143 | FGR | 0.37172051 |
| 144 | MOS | 0.36872197 |
| 145 | PTK6 | 0.34401836 |
| 146 | TXK | 0.34041234 |
| 147 | MAPK12 | 0.33006397 |
| 148 | BMX | 0.32902780 |
| 149 | EGFR | 0.32519356 |
| 150 | CDK7 | 0.31140693 |
| 151 | PRKCG | 0.31010015 |
| 152 | MET | 0.30792695 |
| 153 | PDPK1 | 0.30550386 |
| 154 | ARAF | 0.29718887 |
| 155 | MAPKAPK2 | 0.29418716 |
| 156 | FLT3 | 0.29122209 |
| 157 | CSNK1A1 | 0.28916285 |
| 158 | CDK11A | 0.28804761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.71069114 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.00036534 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.80469362 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72610455 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.62774425 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.34691230 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23722255 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22957761 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.21883617 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.17753055 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 2.16252042 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.08463516 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.05800395 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.04776238 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.92871905 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.90663502 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.86835242 |
| 18 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.84826769 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81073093 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.79439516 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.78217676 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77267593 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74459566 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.63865147 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.58567499 |
| 26 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.49147790 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47123311 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.45058450 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44940103 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.44217568 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42532113 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42269771 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41268911 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39664884 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35526769 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.34853360 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33993718 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32506082 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31686778 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.28921921 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28862193 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28643634 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 1.28239275 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.27144485 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25603199 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24363178 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.23723829 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20758835 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.20002624 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15078964 |
| 51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.13959262 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.13790730 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.10783119 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09611206 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.08722010 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07363794 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.07138303 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05802816 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05292931 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04410053 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98360136 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97052711 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94006422 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93847096 |
| 65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92806388 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92460868 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90996806 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89716574 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.88337999 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.88169522 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87534488 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.86514367 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86303499 |
| 74 | Base excision repair_Homo sapiens_hsa03410 | 0.85157834 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84654603 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84592181 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.84258577 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83457411 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79607422 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79172770 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78438553 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77450158 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75352874 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.74557138 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73909027 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73864336 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.72561802 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.72482028 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70728457 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67404411 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67040826 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.61738323 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.61355219 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61240774 |
| 95 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.60988417 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60802017 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59141447 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58763409 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58590322 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58292457 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55725457 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55215664 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54697435 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.53774537 |
| 105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52708919 |
| 106 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52369129 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51620960 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.51333117 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50775084 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50364532 |
| 111 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49943757 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49074314 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48945317 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48693679 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47768282 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45174819 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44965055 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43796882 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42743436 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.41656327 |
| 121 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40754350 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39353592 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39192782 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.38132643 |
| 125 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.37592248 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.37404581 |
| 127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37299452 |
| 128 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.37203374 |
| 129 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34519312 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34452643 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32088560 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30435126 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.29488367 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27587430 |
| 135 | Hepatitis C_Homo sapiens_hsa05160 | 0.22028534 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21278651 |
| 137 | Alzheimers disease_Homo sapiens_hsa05010 | 0.20022578 |

